Screener
Corcept Therapeutics CORT Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $42.99M+22.3% | -$31.76M-255% | $24.29M-21.0% | $19.67M-58.3% | $35.15M-1.0% | ||
| $863K+202% | $598K+110% | $289K+2.8% | $289K-9.1% | $286K+123% | ||
| $29.42M+54.6% | $23.04M+5.6% | $20.77M+23.6% | $22.88M+42.1% | $19.02M+25.1% | ||
| $33.54M-23.7% | -$16.77M-427% | $38.45M-35.2% | $54.48M-26.2% | $43.94M+6.7% | ||
| $2.53M+4,335% | $201K+93.3% | $50K-58.7% | $0-100% | $57K-86.3% | ||
| -$29.24M-142% | $4.54M+243% | —— | $14.65M+133% | $70.13M+217% | ||
| $0-100% | $0-100% | $0— | $42.46M+263% | $103.02M+2,862% | ||
| -$2.04M+98.0% | $760K+102% | -$31.22M-584% | -$46.41M-120% | -$102.93M-4,688% | ||
| —— | -$11.76M+68.9% | -$4.64M+51.8% | —— | —— | ||
| $31.02M-29.3% | -$16.97M-438% | $38.4M-35.1% | $54.48M-24.5% | $43.88M+7.6% |
FAQ
- How much cash does Corcept Therapeutics generate?
- Corcept Therapeutics (CORT) generated $109.7M in operating cash flow over the trailing twelve months.
- What is Corcept Therapeutics's free cash flow?
- After $2.8M of capital expenditures, Corcept Therapeutics's free cash flow was $106.9M over the trailing twelve months, down 40.7% year over year.
- Where does Corcept Therapeutics's cash flow data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
